Viracta Therapeutics's market cap is currently $1.17M. The company's EPS TTM is $-1.103; its P/E ratio is ―; Viracta Therapeutics is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 120.00K	$ 2.07M
Gross Profit	$ -492.00K	$ -210.00K	$ -178.00K	$ 88.00K	$ 2.07M
Operating Income	$ -50.69M	$ -50.59M	$ 62.50M	$ -18.82M	$ -23.29M
EBITDA	$ -46.86M	$ -48.41M	$ -114.09M	$ -18.77M	$ -22.82M
Net Income	$ -51.06M	$ -49.77M	$ -203.06M	$ -19.20M	$ -23.33M
Balance Sheet
Cash & Short-Term Investments	$ 53.69M	$ 91.04M	$ 103.55M	$ 47.09M	$ 34.63M
Total Assets	$ 56.69M	$ 95.99M	$ 108.55M	$ 48.30M	$ 37.24M
Total Debt	$ 25.56M	$ 25.16M	$ 5.48M	$ 6.18M	$ 6.28M
Net Debt	$ 13.24M	$ -11.62M	$ -98.08M	$ -40.91M	$ -11.98M
Total Liabilities	$ 38.37M	$ 34.89M	$ 14.18M	$ 94.50M	$ 9.70M
Stockholders' Equity	$ 18.32M	$ 61.10M	$ 94.37M	$ -46.20M	$ 27.54M
Cash Flow
Free Cash Flow	$ -40.03M	$ -35.50M	$ -23.10M	$ -16.11M	$ -22.18M
Operating Cash Flow	$ -39.89M	$ -35.46M	$ -18.85M	$ -16.05M	$ -22.18M
Investing Cash Flow	$ 15.00M	$ -53.87M	$ 12.89M	$ -55.00K	$ -16.29M
Financing Cash Flow	$ 438.00K	$ 22.54M	$ 62.42M	$ 44.98M	$ 43.03M

Currency in USD

Viracta Therapeutics Earnings and Revenue History

Income Statement >

Viracta Therapeutics Debt to Assets

Balance Sheet >

Viracta Therapeutics Cash Flow

Cash Flow >

Viracta Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing